e-learning
resources
London 2016
Sunday, 04.09.2016
Cystic fibrosis: monitoring and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant dysfunction in cystic fibrosis: Mechanisms and reversal with a cyclodextrin drug
Francis H Y Green (Calgary, Canada), Francis H.Y. Green, Mustafa Mustafa Al-Saiedy, Lasantha Gunasekara, Candice Bjornson, Ailian Yang, Andrea Chiu, Mark Montgomery, John Dennis, Matthias Amrein
Source:
International Congress 2016 – Cystic fibrosis: monitoring and management
Session:
Cystic fibrosis: monitoring and management
Session type:
Oral Presentation
Number:
1494
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Francis H Y Green (Calgary, Canada), Francis H.Y. Green, Mustafa Mustafa Al-Saiedy, Lasantha Gunasekara, Candice Bjornson, Ailian Yang, Andrea Chiu, Mark Montgomery, John Dennis, Matthias Amrein. Surfactant dysfunction in cystic fibrosis: Mechanisms and reversal with a cyclodextrin drug. Eur Respir J 2016; 48: Suppl. 60, 1494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Resveratrol regulates ECM remodeling in lung fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Proteasome function in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014
LATE-BREAKING ABSTRACT: Age-related PINK1 deficiency promotes mitochondria dysfuntion, epithelial injury and fibrosis in the lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015
Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Proteasome function in lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Lung clearance index in young children with atypical CF
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
The role of 5-HT2 receptors in the early development of lung fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Tracking pulmonary exacerbations in preschool children using the lung clearance index
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014
The role of Frizzled8 in idiopathic pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Lung Clearance Index (LCI) and FEV
1
on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Chronic epithelial injury in Diffuse Parenchymal Lung Diseases (DPLD) cellular consequences and therapeutic prospects
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept